Activating killer-cell immunoglobulin-like receptor haplotype influences clinical outcome following HLA-matched sibling haematopoietic stem cell transplantation

MLA

Peter Bardy, et al. “Activating Killer-Cell Immunoglobulin-like Receptor Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Haematopoietic Stem Cell Transplantation.” HLA, vol. 92, Aug. 2018, pp. 74–82. EBSCOhost, https://doi.org/10.1111/tan.13327.

APA

Peter Bardy, Lucy C. Sullivan, Anthony P. Schwarer, Uwe Hahn, Charles G. Mullighan, Kathleen Doherty, Geraldine M. O’Connor, Silke Danner, Jeff Szer, Susan L. Heatley, Andrew G. Brooks, & Kenneth F. Bradstock. (2018). Activating killer-cell immunoglobulin-like receptor haplotype influences clinical outcome following HLA-matched sibling haematopoietic stem cell transplantation. HLA, 92, 74–82. https://doi.org/10.1111/tan.13327

Chicago

Peter Bardy, Lucy C. Sullivan, Anthony P. Schwarer, Uwe Hahn, Charles G. Mullighan, Kathleen Doherty, Geraldine M. O’Connor, et al. 2018. “Activating Killer-Cell Immunoglobulin-like Receptor Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Haematopoietic Stem Cell Transplantation.” HLA 92 (August): 74–82. doi:10.1111/tan.13327.